# EDGAR Filing Document

**Accession Number:** 0001053369
**File Stem:** 0000000000-26-003759
**Filing Date:** 2026-4
**Character Count:** 2036
**Document Hash:** 03cb3fc5a5fd653da7bd363c652d8b2a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-003759.hdr.sgml**: 20260514

**ACCESSION NUMBER**: 0000000000-26-003759

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260414

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ELITE PHARMACEUTICALS INC /NV/
- **CENTRAL INDEX KEY:** 0001053369
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 223542636
- **STATE OF INCORPORATION:** NJ
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 001-15697

**BUSINESS ADDRESS:**
- **STREET 1:** 165 LUDLOW AVENUE
- **CITY:** NORTHVALE
- **STATE:** NJ
- **ZIP:** 07647
- **BUSINESS PHONE:** 2017502646

**MAIL ADDRESS:**
- **STREET 1:** 165 LUDLOW AVENUE
- **CITY:** NORTHVALE
- **STATE:** NJ
- **ZIP:** 07647

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ELITE PHARMACEUTICALS INC /DE/
- **DATE OF NAME CHANGE:** 19980121
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001641172-25-017134

## Text-Extract

```

                                                          April 14, 2026

Carter Ward
Chief Financial Officer
Elite Pharmaceuticals, Inc.
165 Ludlow Avenue
Northvale, New Jersey 07647

       Re: Elite Pharmaceuticals, Inc.
           Form 10-K for the Fiscal Year Ended March 31, 2025
           Filed June 30, 2025
           File No. 001-15697
Dear Carter Ward:

       We have completed our review of your filing. We remind you that the
company and its
management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding
any review, comments, action or absence of action by the staff.

                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of Life
Sciences

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._